Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening

•As treatments for cystic fibrosis (CF) improve life expectancy, complications that increase in prevalence with age such as CF-related bone disease (CFBD) require more attention and investigation.•Demineralization of the bones can have detrimental consequences on the lives of people with CF, including rib and spinal fractures, chronic pain, and potentially barriers to transplantation.•Despite guidelines on bone mineral density screening published by organizations such as the CF Foundation in the United States, systematic screening practices across care centers has not been universally adapted.•This evaluation of bone density screening practices reported in the United States CF Foundation patient registry showed that in individuals with CF with less severe disease, such as higher lung function, younger age, and pancreatic sufficiency, screened was less likely than those with more traditional risks for bone disease.•This study highlights the need for CF care centers to create processes to ensure adherence to bone density screening recommendations.